Viant Technology Stock (NASDAQ:DSP), Trade Ideas

Viant Technology

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. Through the technology, a marketer can easily buy ads on desktop, mobile, connected TV, linear TV, streaming audio and digital billboards.

News

Price Target

Small Cap

Markets

Analyst Ratings

Trading Ideas

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

VEEV

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday

Earnings

Viant Technology (NASDAQ: DSP) reported better-than-expected fourth-quarter adjusted earnings results and issued first-quarter revenue guidance above estimates.

Viant Technology Analysts Boost Their Forecasts Following Upbeat Earnings

Pre-Market Outlook

BNTX

CSTM

ENPH

MTRN

TEVA

Enphase Energy To Rally Over 35%? Here Are 10 Top Analyst Forecasts For Tuesday

Viant Technology Inc

SUPERNOVA DIGITAL ASSETS by SUPERNOVA DIGITAL ASSETS PLC

Supernova Digital Assets Plc

Dorchester Capital Acquisition Corp.

Denham Sustainable Performance Acquisition Corp

<p>--&nbsp;Iomab-B led bone marrow transplant produced high rates of complete remission and durable complete remission regardless of TP53 mutation status in patients age 55 and above with high-risk active relapsed or refractory acute myeloid leukemia</p>
<p>-- Median Overall Survival of 5.49 months observed in patients with a TP53 mutation receiving an&nbsp;Iomab-B led allogeneic bone marrow transplant compared to 1.66 months in patients that did not receive Iomab-B (hazard ratio=0.23, p=0.0002)</p>
<p>NEW YORK, April 18, 2024 /PRNewswire/ -- <strong>Actinium Pharmaceuticals, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATNM#NYSE">ATNM</a>) (Actinium or the Company), a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies, today announced that results from the Phase 3 SIERRA trial of Iomab-B were presented in an oral presentation at the 50th Annual European Bone Marrow Transplant Society Meeting (EBMT) held in Glasgow, Scotland on April 14-17. The results showed that an Iomab-B led bone marrow transplant (BMT) results in higher rates of remissions and durable Complete Remission (dCR), which is the primary endpoint of the SIERRA trial, as well as significant improvement in overall survival in TP53 positive patients. Iomab-B is a targeted radiotherapeutic comprised of an anti-CD45 monoclonal antibody with the Iodine-131 radioisotope payload. The Phase 3 SIERRA trial enrolled 153 patients age 55 and above with active relapsed or refractory acute myeloid leukemia (AML) and compared outcomes of patients receiving Iomab-B BMT to those of patients receiving physician's choice of care in the control arm. In total, 24% (37/153) of the patients enrolled on SIERRA had a TP53 mutation, which is associated with limited treatment options and poor outcomes.</p>
<p>Data highlighted in the ASH oral presentation, which can be accessed on the investor relations page of Actinium's website, included:</p>
<p><strong>Response rates by TP53 Mutation Status:</strong></p>
<p><figure class="table"><br />
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="1" rowspan="1"><strong>Iomab-B &amp; Crossover</strong></td>
<td colspan="1" rowspan="1"><strong>Control Arm</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1">TP53 Positive</td>
<td colspan="1" rowspan="1"><strong>N=27</strong></td>
<td colspan="1" rowspan="1"><strong>N=10</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"><strong>CR</strong></td>
<td colspan="1" rowspan="1"><strong>55.56% (15/27)</strong></td>
<td colspan="1" rowspan="1"><strong>0&nbsp;%</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"><strong>dCR</strong></td>
<td colspan="1" rowspan="1"><strong>14.81% (4/27)</strong></td>
<td colspan="1" rowspan="1"><strong>0&nbsp;%</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1">TP53 Wildtype</td>
<td colspan="1" rowspan="1"><strong>N=93</strong></td>
<td colspan="1" rowspan="1"><strong>N=23</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"><strong>CR</strong></td>
<td colspan="1" rowspan="1"><strong>58.06% (54/93)</strong></td>
<td colspan="1" rowspan="1"><strong>17.39% (4/23)</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"><strong>dCR</strong></td>
<td colspan="1" rowspan="1"><strong>16.13% (15/93)</strong></td>
<td colspan="1" rowspan="1"><strong>0&nbsp;%</strong></td>
</tr>
</tbody>
</table>
<p></p></figure>
</p><p><strong>Overall Survival in Patients with a TP53 Mutation:</strong></p>
<p><figure class="table"><br />
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1"><br /><br />&nbsp;</td>
<td colspan="1" rowspan="1"><strong>Iomab-B &amp; Crossover</strong></td>
<td colspan="1" rowspan="1"><strong>Control Arm</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"><strong>Median OS</strong></td>
<td colspan="1" rowspan="1">5.49 months</td>
<td colspan="1" rowspan="1">1.66 months</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><strong>Number of Patients</strong></td>
<td colspan="1" rowspan="1">27</td>
<td colspan="1" rowspan="1">10</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><strong>Hazard Ratio</strong></td>
<td colspan="2" rowspan="1"><strong>0.23</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"><strong>p-value</strong></td>
<td colspan="2" rowspan="1"><strong>0.0002</strong></td>
</tr>
</tbody>
</table>
<p></p></figure>
</p><p>Median OS was 6.37 months in TP53 negative patients receiving Iomab-B and 5.72 months for TP53 positive patients demonstrating Iomab-B's ability to overcome TP53 gene mutations.</p>
<p>Dr. Hannah Choe, Assistant Professor of Medicine at Ohio State University and SIERRA trial investigator, commented, "TP53 mutations are associated with very poor&nbsp;outcomes due to resistance to anti-leukemic therapies with patients rarely offered access to potentially curative transplantation. The SIERRA trial showed that Iomab-B was well tolerated and can enable unprecedented access to transplant in this patient population and induce high complete remission rates despite active, relapsed/refractory disease and a TP53 mutation. These results were very well received at EBMT and demonstrate the novelty and safety of a CD45-directed antibody radiation conjugate. More importantly, we see that these response rates translated into improved overall survival, overcoming the increased risk associated with TP53 mutation while no other viable treatment options exist. We are excited for Iomab-B's potential use and safety for disease control in patients with a TP53 mutation."</p>


Biotech

General

ATNM

Actinium Highlights Ability Of Iomab-B To Overcome High-Risk TP53 Mutation Resulting In Improvement In Overall Survival In Patients With Active Relapsed Refractory AML At The European Bone Marrow Transplant Annual Meeting

WIIM

AGBA

AGBA Group Holding shares are trading higher after the company announced it entered into a definitive merger agreement with Triller.

<p>Deutsche Bank  analyst Justin Bowers   maintains Avantor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) with a Hold and raises the price target from $23 to $25.</p>


AVTR

Deutsche Bank Maintains Hold on Avantor, Raises Price Target to $25

<p>JonesTrading  analyst Catherine Novack   initiates coverage on Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) with a Buy rating and announces Price Target of $10.</p>


Initiation

RZLT

JonesTrading Initiates Coverage On Rezolute with Buy Rating, Announces Price Target of $10

<h3>Companies Reporting Before The Bell</h3>
<p>&bull; Addex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) is estimated to report earnings for its fourth quarter.</p>
<p>&bull; Nokia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $5.09 billion.</p>
<p>&bull; Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) is likely to report quarterly earnings at $1.31 per share on revenue of $18.41 billion.</p>
<p>&bull; TH International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THCH#NASDAQ">THCH</a>) is projected to report earnings for its fourth quarter.</p>
<p>&bull; Ohmyhome (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMH#NASDAQ">OMH</a>) is likely to report earnings for its Fiscal Year 2023.</p>
<p>&bull; Alaska Air Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) is likely to report quarterly loss at $0.97 per share on revenue of $2.13 billion.</p>
<p>&bull; Snap-on (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) is projected to report quarterly earnings at $4.65 per share on revenue of $1.20 billion.</p>
<p>&bull; Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $253.42 million.</p>
<p>&bull; Infosys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $4.55 billion.</p>
<p>&bull; Berkshire Hills Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHLB#NYSE">BHLB</a>) is expected to report quarterly earnings at $0.47 per share on revenue of $89.01 million.</p>
<p>&bull; Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $1.98 billion.</p>
<p>&bull; Genuine Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) is estimated to report quarterly earnings at $2.16 per share on revenue of $5.84 billion.</p>
<p>&bull; Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) is likely to report quarterly earnings at $1.12 per share on revenue of $807.79 million.</p>
<p>&bull; KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) is expected to report quarterly earnings at $0.22 per share on revenue of $1.51 billion.</p>
<p>&bull; Elevance Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) is projected to report quarterly earnings at $10.49 per share on revenue of $42.62 billion.</p>
<p>&bull; Badger Meter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMI#NYSE">BMI</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $182.26 million.</p>
<p>&bull; S&amp;T Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBA#NASDAQ">STBA</a>) is expected to report quarterly earnings at $0.79 per share on revenue of $95.94 million.</p>
<p>&bull; ManpowerGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) is likely to report quarterly earnings at $0.91 per share on revenue of $4.43 billion.</p>
<p>&bull; Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) is expected to report quarterly earnings at $0.98 per share on revenue of $2.53 billion.</p>
<p>&bull; Iridium Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $193.75 million.</p>
<p>&bull; Apogee Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APOG#NASDAQ">APOG</a>) is expected to report quarterly earnings at $1.01 per share on revenue of $337.83 million.</p>
<p>&bull; OFG Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OFG#NYSE">OFG</a>) is projected to report quarterly earnings at $0.97 per share on revenue of $152.67 million.</p>
<p>&bull; Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) is estimated to report quarterly earnings at $2.80 per share on revenue of $6.39 billion.</p>
<p>&bull; Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) is expected to report quarterly earnings at $0.46 per share on revenue of $240.40 million.</p>
<p>&bull; Forestar Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) is projected to report quarterly earnings at $0.72 per share on revenue of $325.91 million.</p>
<p>&bull; D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) is likely to report quarterly earnings at $3.06 per share on revenue of $8.28 billion.</p>
<h3>Companies Reporting After The Bell</h3>
<p>&bull; Hilltop Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTH#NYSE">HTH</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $109.71 million.</p>
<p>&bull; Five Point Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FPH#NYSE">FPH</a>) is expected to report earnings for its first quarter.</p>
<p>&bull; Provident Finl Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFS#NYSE">PFS</a>) is expected to report quarterly earnings at $0.40 per share on revenue of $92.95 million.</p>
<p>&bull; Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) is expected to report quarterly earnings at $1.67 per share on revenue of $697.64 million.</p>
<p>&bull; Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDB#NASDAQ">INDB</a>) is estimated to report quarterly earnings at $1.11 per share on revenue of $174.77 million.</p>
<p>&bull; Banco Latinoamericano (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLX#NYSE">BLX</a>) is expected to report earnings for its first quarter.</p>
<p>&bull; Glacier Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBCI#NYSE">GBCI</a>) is expected to report quarterly earnings at $0.34 per share on revenue of $171.99 million.</p>
<p>&bull; First Western Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYFW#NASDAQ">MYFW</a>) is expected to report quarterly earnings at $0.22 per share on revenue of $22.97 million.</p>
<p>&bull; Alpine Income Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINE#NYSE">PINE</a>) is projected to report quarterly earnings at $0.38 per share on revenue of $11.63 million.</p>
<p>&bull; Metropolitan Bank Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCB#NYSE">MCB</a>) is projected to report quarterly earnings at $1.34 per share on revenue of $64.56 million.</p>
<p>&bull; Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) is likely to report quarterly earnings at $4.50 per share on revenue of $9.26 billion.</p>
<p>&bull; OceanFirst Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCFC#NASDAQ">OCFC</a>) is likely to report quarterly earnings at $0.41 per share on revenue of $87.72 million.</p>
<p>&bull; PPG Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) is expected to report quarterly earnings at $1.86 per share on revenue of $4.43 billion.</p>
<p>&bull; SB Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFG#NASDAQ">SBFG</a>) is estimated to report quarterly earnings at $0.30 per share on revenue of $9.50 million.</p>
<p>&bull; Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) is estimated to report quarterly earnings at $1.41 per share on revenue of $1.87 billion.</p>
<p>This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.</p>


ADXN

ALLY

APOG

BHLB

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

GBCI

HOMB

INDB

INFY

IRDM

ISRG

MYFW

NFLX

OCFC

PINE

SBFG

STBA

TCBI

THCH

Earnings Scheduled For April 18, 2024

<h3>Gainers</h3>
<ul>
<li><strong>Secoo Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SECO#NASDAQ">SECO</a>) shares increased by 17.4% to $0.43 during Thursday's pre-market session. The company's market cap stands at $3.0 million. </li>
<li><strong>TH International</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THCH#NASDAQ">THCH</a>) shares moved upwards by 16.34% to $1.21. The market value of their outstanding shares is at $190.6 million. As per the news, the Q4 earnings report came out today. </li>
<li><strong>Lixiang Education Hldg</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) stock rose 8.52% to $0.43. The market value of their outstanding shares is at $2.8 million. </li>
<li><strong>EVgo</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) shares increased by 8.33% to $1.95. The market value of their outstanding shares is at $206.9 million. </li>
<li><strong>2U</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) stock moved upwards by 7.89% to $0.3. The company's market cap stands at $25.3 million. </li>
<li><strong>Golden Heaven Group Hldgs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) stock moved upwards by 7.31% to $0.23. The market value of their outstanding shares is at $11.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>The One Group Hospitality</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) stock decreased by 35.3% to $3.43 during Thursday's pre-market session. The market value of their outstanding shares is at $107.3 million. </li>
<li><strong>Funko</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) shares fell 12.09% to $5.02. The market value of their outstanding shares is at $266.4 million. </li>
<li><strong>Kidpik</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) shares decreased by 9.72% to $3.81. The market value of their outstanding shares is at $7.4 million. </li>
<li><strong>Jianzhi Education Tech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) shares decreased by 6.52% to $2.01. The company's market cap stands at $40.5 million. </li>
<li><strong>Zapp Electric Vehicles</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) shares fell 5.27% to $0.16. The market value of their outstanding shares is at $9.7 million. </li>
<li><strong>Barnes &amp; Noble Education</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) shares declined by 5.24% to $0.23. The company's market cap stands at $12.2 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Movers

BNED

EVGO

FNKO

GDHG

LXEH

SECO

STKS

TWOU

ZAPP

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li><strong>Bio-Path Hldgs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares increased by 43.8% to $4.66 during Thursday's pre-market session. The market value of their outstanding shares is at $3.5 million. </li>
<li><strong>SINTX Techs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) shares moved upwards by 39.41% to $0.05. The company's market cap stands at $6.3 million. </li>
<li><strong>23andMe Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ME#NASDAQ">ME</a>) stock moved upwards by 26.61% to $0.45. The company's market cap stands at $217.7 million. </li>
<li><strong>Benitec Biopharma</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) shares rose 25.62% to $6.03. The company's market cap stands at $15.6 million. </li>
<li><strong>Trevena</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) stock moved upwards by 22.86% to $0.49. The company's market cap stands at $9.0 million. </li>
<li><strong>Citius Pharma</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) stock moved upwards by 16.38% to $0.95. The company's market cap stands at $151.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>NRX Pharmaceuticals</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) shares declined by 22.5% to $3.24 during Thursday's pre-market session. The company's market cap stands at $31.0 million. </li>
<li><strong>Soligenix</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock decreased by 17.61% to $0.42. The market value of their outstanding shares is at $4.4 million. </li>
<li><strong>Sonoma Pharmaceuticals</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOA#NASDAQ">SNOA</a>) stock declined by 13.75% to $0.14. The company's market cap stands at $2.2 million. </li>
<li><strong>Mustang Bio</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares fell 11.12% to $0.34. The company's market cap stands at $3.5 million. </li>
<li><strong>Dynatronics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock fell 10.26% to $0.53. The market value of their outstanding shares is at $2.5 million. </li>
<li><strong>SeaStar Medical Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) shares decreased by 9.46% to $0.63. The company's market cap stands at $47.7 million. As per the press release, Q4 earnings came out 2 days ago.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BNTC

BPTH

CTXR

DYNT

MBIO

NRXP

SINT

SNGX

SNOA

TRVN

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<p><i>Best-in-class identity fraud prevention, coupled with a secure, frictionless user experience</i><br /><br /><i>&nbsp;to fortify a revolutionary online notary platform</i></p>
<p>Denver, April 18, 2024 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=zfmUIzK3XiTre6-ZouBdxCl9_H2ctkuC-U-tdLDZ2DBaJimflgd-9yI5fA3g5dHF54kDwBGIdLUNZlHaqU0tNA=="><strong>authID Inc.</strong></a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>), a leading provider of secure, biometric identity verification and authentication solutions and <a href="https://www.globenewswire.com/Tracker?data=8NtSB7Ribxg8nlhHrRPyhJi20CwR4Rckl9QWNqjDRLueOeLns8NhCNv5Gc0uI2N9aNW4l3ohuRWucPD12yccEVL8Egk-ao8jb0voUFLJ1yNj2KkNZ7C-KUeeHZYQ0hbw6MEyyFWtXURGawQA7P2hfttf8sWwLrGmKqWf9xJbMQo=">National Notarial Centralized Verification System</a> (NNCVS), today announced that NNCVS will deploy authID's biometric identity life-cycle platform to provide real-time identity assurance to the company's innovative online technology platform for commissioned notaries and their clients. With increasing frequency of social engineering fraud, deepfakes, and ransomware attacks, NNCVS selected authID's for its ability to stop fraud, detect deepfakes, and combat adversarial generative AI, all while delivering a fast, seamless user authentication experience.&nbsp;</p>
<p>Providing the first-ever nationwide verification system for notaries, the NNCVS platform is transforming the current ‘localized and in-person' notary industry into a robust national online service that makes notarization faster, more efficient, and more secure. Offering 24/7 access, NNCVS authenticates notary agent and signer identities and facilitates data sharing among notaries in real-time, while maintaining high-security protocols to protect against fraud.</p>
<p>"authID's next-gen biometric identity platform is paramount to our mission to revolutionize the notary industry by providing strong identity assurance that prevents fraudulent account openings and phishing-related account takeovers, while delivering the convenience today's online users expect," said Stefan Perez Tejera, CEO of National Notarial Centralized Verification System. "Together, NNCVS and authID are driving high identity trust in our platform, so our valued network of notaries public, lawyers, and signing agents can easily provide their verified customers with safe notary services."</p>
<p>NNCVS will leverage authID's&nbsp;<a href="https://www.globenewswire.com/Tracker?data=DlIJ6IU8rh3wCbUnx0AVsgXVS7-Y1h4k6U0b6iCs-FNlaE5uk59PddfzKhgELkmuGVAsNQP5Rx1-7cehH1Zz_Paccn-wzdUQjVpF0eC-rVLFh5543tHYGQOqavCIOLSNFtQ62DGmdceKAQVtsW7qyISTsNzWuBO0H3a96fTmasE=">biometric and document-based identity verification&nbsp;</a>to verify identities of new notarial agents and their clients with speed and high identity assurance.&nbsp; During online onboarding, authID delivers a strong biometric root of trust identity through automated document verification of 13,800 US and international government-issued ID documents, detecting and thwarting deepfakes, injection attacks and presentation attacks with PAD (Presentation Attack Detection) Level 2 accuracy, and processing a biometric matching of a selfie to the credential photo.</p>
<p>authID's life-cycle identity platform delivers continuous security of the entire NNCVS user journey with seamless biometric authentication and an indisputable biometric audit trail that eliminates the risks and hassles of entering easily stolen one-time PINs or recalling easily hacked secret questions or personal information. authID authenticates the identity of the true account owner every time with the <a href="https://www.globenewswire.com/Tracker?data=Ru9tBwsQvVb5I62p8GoTgs0I-EeiJ7Qbgw9t1mkGuICxK0JcUaq_Ra-FbjLBnhSO2U2z2TFqesQnOnc34Ot6zpDnrTtjvtKPFY4-6MCnnISUz_8K-CI53NIftrJwppJhgpi037ZHBlXteZ3AP6YLyQ==">ease of a quick selfie</a> captured and validated in 700 milliseconds—the fastest on the market— thus delivering the fast, frictionless, and precise user identity authentication demanded by today's digital ecosystems.</p>
<p>"authID ensures that digital enterprises ‘Know Who Is Behind the Device' during onboarding and throughout the user journey to prevent cybercriminals from impersonating users, deploying deepfakes, or performing account takeovers and seizing assets," said Rhon Daguro CEO of authID. "We are excited to help National Notarial Centralized Verification System revolutionize the notary industry by delivering the highest levels of identity trust with market leading speed, precision and accuracy, while deepening user trust with frictionless identity experiences."</p>


AUID

authID Selected By National Notarial Centralized Verification System For Secure Biometric Identity Assurance

<h3>Gainers</h3>
<ul>
<li><strong>Tritium DCFC</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCFC#NASDAQ">DCFC</a>) shares rose 15.1% to $4.19 during Thursday's pre-market session. The market value of their outstanding shares is at $4.4 million. </li>
<li><strong>Graphex Gr</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GRFX#AMEX">GRFX</a>) shares moved upwards by 12.55% to $0.24. The company's market cap stands at $10.9 million. </li>
<li><strong>Addentax Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) shares moved upwards by 10.11% to $0.99. The company's market cap stands at $4.2 million. </li>
<li><strong>Globus Maritime</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBS#NASDAQ">GLBS</a>) shares moved upwards by 9.72% to $2.2. The company's market cap stands at $45.2 million. </li>
<li><strong>Roma Green Finance</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROMA#NASDAQ">ROMA</a>) shares rose 7.67% to $0.77. The company's market cap stands at $8.0 million. </li>
<li><strong>Ideanomics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDEX#NASDAQ">IDEX</a>) shares moved upwards by 6.8% to $0.87. The company's market cap stands at $10.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Caravelle Intl Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CACO#NASDAQ">CACO</a>) shares decreased by 10.3% to $0.96 during Thursday's pre-market session. The market value of their outstanding shares is at $50.6 million. </li>
<li><strong>Equifax</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) stock fell 8.71% to $216.98. The market value of their outstanding shares is at $26.9 billion. The company's, Q1 earnings came out yesterday. </li>
<li><strong>Rentokil Initial</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTO#NYSE">RTO</a>) stock fell 6.16% to $26.51. The company's market cap stands at $13.3 billion. </li>
<li><strong>iPower</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) stock fell 5.92% to $0.42. The market value of their outstanding shares is at $12.6 million. </li>
<li><strong>AERWINS Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWIN#NASDAQ">AWIN</a>) shares declined by 4.91% to $3.2. The market value of their outstanding shares is at $2.3 million. </li>
<li><strong>Dragonfly Energy Hldgs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) stock decreased by 4.6% to $0.59. The market value of their outstanding shares is at $35.3 million. As per the press release, Q4 earnings came out 3 days ago.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ATXG

AWIN

CACO

DCFC

DFLI

GLBS

GRFX

IDEX

ROMA

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li><strong>MicroCloud Hologram</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock increased by 48.7% to $3.33 during Thursday's pre-market session. The market value of their outstanding shares is at $19.7 million. </li>
<li><strong>Verb Tech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) stock increased by 18.61% to $0.19. The market value of their outstanding shares is at $15.1 million. </li>
<li><strong>Red Cat Hldgs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock rose 14.78% to $1.63. The market value of their outstanding shares is at $121.0 million. </li>
<li><strong>Rekor Systems</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) shares increased by 12.97% to $2.09. The market value of their outstanding shares is at $178.3 million. </li>
<li><strong>Smith Micro Software</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>) shares rose 12.3% to $2.19. The company's market cap stands at $21.0 million. </li>
<li><strong>Mercurity Fintech Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) stock increased by 11.88% to $1.6. The company's market cap stands at $97.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Canaan</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) shares decreased by 22.4% to $0.86 during Thursday's pre-market session. The market value of their outstanding shares is at $201.7 million. </li>
<li><strong>VIA optronics</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIAO#NYSE">VIAO</a>) shares declined by 11.61% to $0.23. The company's market cap stands at $5.2 million. </li>
<li><strong>Spectaire Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPEC#NASDAQ">SPEC</a>) stock decreased by 10.48% to $0.7. The market value of their outstanding shares is at $11.7 million. </li>
<li><strong>X3 Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) stock decreased by 8.92% to $0.58. The company's market cap stands at $3.1 million. </li>
<li><strong>Infosys</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>) stock declined by 7.97% to $15.6. The company's market cap stands at $64.5 billion. The company's, Q4 earnings came out today. </li>
<li><strong>DatChat</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) shares declined by 5.73% to $1.15. The market value of their outstanding shares is at $3.4 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


DATS

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

RCAT

REKR

SMSI

SPEC

VERB

VIAO

XTKG

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

<p><a href="https://ir.novavax.com/press-releases/Novavax-to-Supply-Updated-COVID-19-Vaccine-to-Private-Healthcare-Providers-in-the-United-Kingdom" title="https://ir.novavax.com/press-releases/Novavax-to-Supply-Updated-COVID-19-Vaccine-to-Private-Healthcare-Providers-in-the-United-Kingdom">https://ir.novavax.com/press-releases/Novavax-to-Supply-Updated-COVID-19-Vaccine-to-Private-Healthcare-Providers-in-the-United-Kingdom</a></p>


NVAX

Novavax To Supply Updated COVID-19 Vaccine To Private Healthcare Providers In The United Kingdom

<p>BioVie Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIVI#NASDAQ">BIVI</a>), ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that an oral presentation and poster presentation will be shared at the 12th Annual Alzheimer's &amp; Parkinson's Drug Development Summit to be held in Boston, Massachusetts April 23-25.<br /><br />&nbsp;</p>
<p>Additionally, the United States Adopted Names (USAN) Council, and the World Health Organization (WHO) International Nonproprietary Names (INN) expert committee has approved "bezisterim" as the non-proprietary (generic) name for NE3107, an orally active partial NF-κB inhibitor product candidate being studied in Parkinson's Disease and Alzheimer's Disease.</p>
<p>The oral and poster presentations 12th Annual Alzheimer's &amp; Parkinson's Drug Development Summit will provide additional details on how bezisterim appears to have an impact on DNA methylation on 5 different "clocks" measuring biological age and that the extent of DNA methylation is correlated to a series of clinical measures.</p>
<p>The oral presentation titled "<i>Clinical Outcomes and Biomarker Findings from a Randomized, Placebo-Controlled Trial of NE3107 in Subjects with Mild to Moderate Probably Alzheimer's Disease"</i> will be presented by Christopher L. Reading, BioVie's Senior Vice President, Alzheimer's Disease Program, on Wednesday, April 24 at 2:30 p.m. EDT. The poster with the same title will be presented at 6:45 p.m. on the same day.</p>
<p>Details of the presented data and conclusions will be announced once the presentations are made public at the conference.</p>


BIVI

BioVie To Present Data Showing How NE3107 Potentially Restores Homeostasis Via Specific Genes Associated With Dementia, Metabolism, And Inflammation

<p>B of A Securities  analyst Ken Hoexter   maintains Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) with a Buy and lowers the price target from $58 to $54.</p>


B of A Securities Maintains Buy on Knight-Swift, Lowers Price Target to $54

Health Care

ATRC

AtriCure Launched cryoSPHERE+ Cryoablation Probe To Reduce Freeze Times By 25% Vs. AtriCure's Legacy cryoSPHERE Device. The Product Is Currently In An Extended Limited Launch Period In US, With Full Launch Expected By The End Of Q2

<p>American Rebel Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) ("American Rebel" or the "Company"), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer (<a href="https://www.globenewswire.com/Tracker?data=08R7TR01f5bkmF04CXK2vEzKSxJotqCRzr4-y7hr2m0WQb_RYz_l9F-pwyiS6vD4DcKhaQqhT0O1aCdXOZdumPdt-mv4n1Gl_3nObCNQ0iI=">www.americanrebelbeer.com</a>), is proud to announce a distribution agreement with Standard Beverage Corporation (<a href="https://www.globenewswire.com/Tracker?data=NY9Ha6hNSAtjSN7OcU2CPqaT2tAMLpVzqon-dN3rJ3JWro0KrcRvzBVE5a4uTMeCX2uBQd8oG2H2FdyyR6T-SwUwzy2l6d0M502mgA9dgZ8s2wPrY9nYmImVyuZyn6CY">www.standardbeverage.com</a>) for the state of Kansas.<br /><br />&nbsp;</p>
<p>"We are excited to work with Standard Beverage to distribute American Rebel Beer throughout the state of Kansas,<strong>" </strong>said Andy Ross, Chief Executive Officer of American Rebel. "We already have commitments from some of the top sports bars, retail outlets, venues and music festivals in the state. Launching America's Patriotic, God-Fearing, Constitution-Loving, National Anthem Singing, Stand Your Ground Beer into the marketplace is a primary goal of our current Reg A+ offering and having American Rebel Light Beer available in the state of Kansas helps deliver on that goal. Interested investors 18 years or older can log onto our public offering website at invest.americanrebel.com and subscribe to the offering."</p>
<p>Standard Beverage will begin distributing American Rebel Light Beer as soon as product can be integrated into the Standard Beverage network<strong>. </strong>This agreement will make American Rebel Beer available to locations and customers within Standard Beverage's territory statewide in Kansas.</p>
<p>This is an ideal partnership between American Rebel Beer and Standard Beverage Corporation, who both have deep roots in the Kansas City suburb of Lenexa, Kansas, where Standard Beverage has a new 83,000-square-foot facility and American Rebel has its flagship retail store. Standard Beverage was started by Sam Rudd in the Wichita area in 1949, just a year after Kansas ended its prohibition laws, and received one of the first alcohol wholesaler licenses in the state. Standard Beverage is still run by the Rudd family, and today is "the largest single alcohol distributor" in Kansas.</p>
<p><br />&nbsp;</p>


AREB

American Rebel Reaches Distribution Agreement With Standard Beverage Corporation Of Kansas For American Rebel Beer

<ul>
<li><i>Centre for Human Drug Research (CHDR) will conduct Phase I trial to evaluate IMP761, a first-in-class LAG-3 agonist antibody designed to restore balance to the immune system and address the underlying cause of autoimmune diseases</i></li>
<li><i>CHDR will utilize its unique challenge model that enables insights into IMP761's pharmacological activity early in clinical development</i></li>
<li><i>Trial expected to begin mid-CY2024</i><br /><br /><br /><br />&nbsp;</li>
</ul>
<p><strong>SYDNEY, AUSTRALIA, April 18, 2024 (GLOBE NEWSWIRE) -- </strong><a href="https://www.globenewswire.com/Tracker?data=NqHRHkZePkKyjcchYfoNIgEm1dfxGt57Cw2LY6ctShcO6TfPjS9_HXMEBqyIl8WvK6T-josdVFkyxQl4tVaGhQ==">Immutep Limited</a> ((ASX: IMM, NASDAQ:<a href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) ("Immutep" or "the Company"), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has entered into an agreement with the <a href="https://www.globenewswire.com/Tracker?data=HA9sPVCwZ6q5X863D8vKIqjPYdDWpbBA_nI8xfdBAXeA1DJbnkXQIwif4xR5Bh_zoM-0z0CPDrZ7VHhZlIiIF5xmOyDEHwGKIooi09N3OlE=">Centre for Human Drug Research (CHDR)</a>, a world-class institute in Leiden, the Netherlands specializing in cutting-edge early-stage clinical drug research, to perform a first-in-human clinical study of IMP761. This proprietary LAG-3 agonist antibody has been designed to restore balance to the immune system and address the underlying cause of many autoimmune diseases.</p>
<p>Subject to the relevant ethic and regulatory approvals, the single and multiple ascending dose, placebo-controlled, double-blind, Phase I study will enrol approximately 49 healthy volunteers, with the objective of assessing safety, pharmacokinetics (PK) and pharmacodynamics (PD). The study will implement CHDR's unique keyhole limpet haemocyanin (KLH) challenge model that allows for the evaluation of immunomodulatory agents' pharmacological activity at the earliest stages of clinical development.</p>
<p>Immutep's Chief Scientific Officer, Frédéric Triebel, M.D., Ph.D., stated, "IMP761 is a first-in-class LAG-3 agonist antibody developed to reinforce the dampening of T cell responses in autoimmunity. The phase I trial in healthy subjects is designed to establish clear PK/PD relationships at different dose levels, with a placebo control group, to lay the foundation for the future development of this novel immunotherapy. We are excited to leverage CHDR's expertise in working with targeted immunotherapy candidates in the clinical setting to evaluate IMP761's potential in changing how autoimmune disorders are treated."</p>
<p>Matthijs Moerland, Ph.D., CHDR's Research Director Immunology and Principal Investigator for the upcoming trial, said, "It is an honour for us to run the first clinical study with IMP761. We're very excited to be partnering with Immutep for this critical step in the development plan of their promising antibody. We are confident that CHDR's unique neoantigen KLH challenge model will help define and measure by dose levels its pharmacological activity in man."</p>
<p>Immune checkpoint agonists, including LAG-3, PD-1, and CTLA-4, are increasingly gaining recognition in the healthcare industry for their inherent ability to treat autoimmune diseases.1 In numerous scientific publications, LAG-3 has been identified as a promising target for agonist immunotherapy for autoimmune disorders including rheumatoid arthritis, Type 1 diabetes, and multiple sclerosis, among others.2,3,4</p>
<p>IMP761 is uniquely positioned as the world's first immunosuppressive LAG-3 agonist antibody. It may address numerous autoimmune diseases by silencing self-antigen-specific memory T cells, which accumulate at disease sites, and preventing their overactivation. This is accomplished through enhancing LAG-3's natural downregulation of auto-reactive memory T cells.&nbsp;IMP761 remains on target to enter the clinic mid-CY2024 and Immutep looks forward to providing more information as it approaches this important milestone.</p>
<p><strong>About&nbsp;IMP761</strong><br /><br />IMP761, a first-in-class immunosuppressive LAG-3 agonist antibody, has the potential to address the root cause of many autoimmune diseases by specifically silencing autoimmune memory T cells that accumulate at disease sites and restoring balance to the immune system. As published in the&nbsp;<a href="https://www.globenewswire.com/Tracker?data=2SW4_voA3bnLfRtdnmEPVv6r2c2e2eO4PXnvjPOnaOaUXygufGd0kZwoba8lTDXilpjHQojudqWhlq4xwJ61UNxLbs3EAUB50RkovDRpkAlXK13mNt7QQxnGReXZGPlKUHxrLBO40JSIOD0BOHkZnYAQOSo9bLnGJvr6yif65i9G3iNg-n4CeQU-G7YKdiXJZISLfER7aJ6kC0OrEIum7A==">Journal of Immunology</a>, encouraging pre-clinical <i>in vivo </i>and<i> in vitro</i> studies show IMP761 inhibits peptide-induced T cell proliferation, activation of human primary T cells, and an antigen-specific delayed-type hypersensitivity (DTH) reaction. Additional preclinical data in oligoarticular juvenile idiopathic arthritis (o-JIA) published in&nbsp;<a href="https://www.globenewswire.com/Tracker?data=BMZWOC_aGRSXL85CqCro6U0PFOoUqVaXk9n9UsfdAZjZpnhkG5U4wgaeCmWJjuiSSIxTYf7PKI8iwsvtIyP3lveWtCFBB1-iU0hzrceeDjVmeebvmK02Ioi-fl-LS0Vt">Pediatric&nbsp;Research</a> details how&nbsp;IMP761&nbsp;led to a decrease in a broad spectrum of effector cytokines in just 48 hours. This study also showed children with o-JIA have a skewed LAG-3 metabolism and suggested they can benefit from agonistic LAG-3 activity.</p>


IMMP

Immutep Appoints Leading Research Institute To Conduct First-in-Human Phase I Study Of IMP761

Wheels Up To Open Maintenance Facility At Palm Beach International Airport

<p>B of A Securities  analyst Andrew Didora   maintains United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) with a Buy and raises the price target from $60 to $70.</p>


B of A Securities Maintains Buy on United Airlines Holdings, Raises Price Target to $70

<p>The Nasdaq 100 closed lower by more than 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.</p>
<p>When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company&rsquo;s prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.</p>
<p>Below is a look at a few recent notable insider sales. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"><em> Benzinga&#39;s insider transactions </em></a> platform.</p>
<h3><strong>Starbucks </strong></h3>
<ul>
<li><strong>The Trade:</strong> <strong> Starbucks Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbux#NASDAQ">SBUX</a>) CEO, North America Michael Aaron Conway <a href="https://www.benzinga.com/sec/insider-trades/"><em> sold a total of 3,250 shares </em></a> at an average price of $85.39. The insider received around $277,518 from selling those shares.</li>
<li><strong>What&rsquo;s Happening:</strong> On April 16, Jefferies analyst Andy Barish maintained Starbucks with a Hold and lowered the price target from $100 to $94.</li>
<li><strong>What Starbucks Does:</strong> Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 38,000 stores across more than 80 countries as of the end of fiscal 2023.</li>
</ul>
<p><em>Have a look at our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> </em></p>
<h3><strong>Alphabet</strong></h3>
<ul>
<li><strong>The Trade:</strong> <strong> Alphabet Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>) CEO Sundar Pichai <a href="https://www.benzinga.com/sec/insider-trades/"><em> sold a total of 22,500 shares </em></a> at an average price of $157.41. The insider received around $3.54 million from selling those shares.</li>
<li><strong>What&rsquo;s Happening:</strong> Following protests over its Israeli government cloud contract, Google&lsquo;s parent company Alphabet has terminated 28 employees.</li>
<li><strong>What Alphabet Does:</strong> Alphabet is a holding company. Internet media giant Google is a wholly owned subsidiary. Google services account for nearly 90% of Alphabet&#39;s revenue, of which more than 85% is from online ads.</li>
</ul>
<h3><strong>NetApp </strong></h3>
<ul>
<li><strong>The Trade:</strong> <strong> NetApp, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntap#NASDAQ">NTAP</a>) CEO George Kurian <a href="https://www.benzinga.com/sec/insider-trades/"><em> sold a total of 8,500 shares </em></a> at an average price of $103.16. The insider received around $876,838 from selling those shares.</li>
<li><strong>What&rsquo;s Happening:</strong> On April 10, NetApp announced a partnership with Google Cloud to maximize flexibility for cloud data storage.</li>
<li><strong>What NetApp Does:</strong> NetApp Inc is a leading provider of enterprise data management and storage solutions. The company&#39;s segments include Hybrid Cloud and Public Cloud.</li>
</ul>
<h3><strong>Trade Desk </strong></h3>
<ul>
<li><strong>The Trade:</strong> <strong> The Trade Desk, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttd#NASDAQ">TTD</a>) President and CEO Jeffrey Terry Green <a href="https://www.benzinga.com/sec/insider-trades/"><em> sold a total of 2,600 shares </em></a> at an average price of $86.41. The insider received around $224,666 from selling those shares.</li>
<li><strong>What&rsquo;s Happening:</strong> On Feb. 15, Trade Desk reported better-than-expected fourth-quarter revenue results and issued first-quarter revenue guidance above estimates.</li>
<li><strong>What Trade Desk Does:</strong> The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on different devices like computers, smartphones, and connected TVs.</li>
</ul>
<p>Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38307448/investor-sentiment-decreases-further-s-p-500-falls-for-fourth-straight-session"><em> Investor Sentiment Decreases Further, S&amp;P 500 Falls For Fourth Straight Session </em></a></p>
<p>&nbsp;</p>


Short Ideas

Insider Trades

GOOG

GOOGL

NTAP

SBUX

Alphabet, NetApp And 2 Other Stocks Insiders Are Selling

<p>Tech billionaire <strong>Elon Musk</strong> has donated to and <a href="https://www.benzinga.com/news/21/01/19115443/elon-musk-sends-signal-downloads-soaring-what-you-should-know-about-the-app">promoted secure messaging app <strong>Signal</strong></a> to take on <strong>Mark Zuckerberg's WhatsApp</strong>, but it's another rival that is closing the gap with the <strong>Meta Platforms Inc.-owned</strong> service.</p>
<p><strong>What Happened:</strong> <strong>Telegram Messenger</strong> creator <strong>Pavel Durov</strong> revealed that his messaging app has nearly a billion users and is spreading like a "forest fire."</p>
<p>Speaking to conservative media personality <strong>Tucker Carlson</strong>, Durov revealed that Telegram is adding users at a breakneck speed of 2.5 million per day.</p>
<p>"Telegram is spreading like forest fire. Two and a half million users sign up every day, and we're sort of a threat."</p>
<p><em>See Also:</em><a href="https://www.benzinga.com/news/24/04/38292771/top-apple-exec-points-to-steve-jobs-era-for-lack-of-meeting-records-casts-doubt-on-app-stores-profit"><em> Top Apple Exec Points To Steve Jobs Era For Lack Of Meeting Records, Expresses Uncertainty About App Store&#8217;s Profitability</em></a></p>
<p>Durov brought this up when Carlson told him that he had heard people claim that "Telegram is a part of the Russian government."</p>
<p>"People who have very limited knowledge of where Telegram came from&#8230; they would make these claims. They could be encouraged by our competitors, who see it as an easy way to discredit us," Durov said, stopping short of naming these rivals.</p>
<p>"I'm not surprised there's this sort of perception."</p>
<p>He went on to say that his competitors spend "tens of billions on marketing" and that they're "known for using public relations (PR) firms to engage in campaigns" like these.</p>
<p><em>Subscribe to the </em><a href="https://bztechtrends.beehiiv.com/subscribe"><em>Benzinga Tech Trends newsletter</em></a><em> to get all the latest tech developments delivered to your inbox.</em></p>
<p><strong>Musk's Calls To Use Signal Run Out Of Steam</strong></p>
<p>While Telegram is now one of the major messaging services globally with nearly a billion users, Musk-backed Signal has not picked up pace yet.</p>
<p>This is despite Musk endorsing Signal on <strong>X</strong>, formerly <strong>Twitter</strong>. While this led to a <a href="https://www.benzinga.com/news/21/01/19115443/elon-musk-sends-signal-downloads-soaring-what-you-should-know-about-the-app">surge in Signal users</a> at the time, it has not taken off in quite the same way as Telegram.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">Use Signal</p>
<p>&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1347165127036977153?ref_src=twsrc%5Etfw">January 7, 2021</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>Musk has even donated to Signal and said he'll "donate more."</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">Already donated to Signal a year ago. Will donate more.</p>
<p>&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1348506592518438914?ref_src=twsrc%5Etfw">January 11, 2021</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Telegram Creator on Elon Musk, Resisting FBI Attacks, and Getting Mugged in California" width="500" height="281" src="https://www.youtube.com/embed/1Ut6RouSs0w?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>
<p><em>Check out more of Benzinga's Consumer Tech coverage by </em><a href="https://www.benzinga.com/topic/consumer-tech"><em>following this link</em></a><em>.</em></p>
<p><em>Read Next:</em><a href="https://www.benzinga.com/markets/equities/24/04/38308198/apples-falling-iphone-sales-have-another-challenge-to-deal-with-as-huawei-launches-new-phones"><em> Apple&#8217;s Falling iPhone Sales Have Another Challenge To Deal With As Huawei Launches New Phones</em></a></p>
<p><em>Photo by Dimitri Karastelev on Unsplash</em></p>


Social Media

Tech

Elon Musk Backed Signal To Take On Mark Zuckerberg's WhatsApp, But Another Rival Says It's Spreading Like A 'Forest Fire': 'We're Sort Of A Threat'

Viant Technology files for $100M mixed securities shelf

Viant Technology: Attractive Price Level With Decent Upside Potential

In a report released today, Jason Kreyer from Craig-Hallum maintained a Buy rating on Viant Technology (DSP – Research Report). The company's share...

Craig-Hallum Sticks to Its Buy Rating for Viant Technology (DSP)

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Most investors are familiar with diversification, such as separating investment capital into different industries in the pursuit of a well-balanced portfolio. This practice is important for a long-term trader, but what may get overlooked is that investing in stocks within varying market caps can also allow investors to gain exposure to smaller companies that may offer investors increased upside in terms of growth.</p>



<p>Below are three companies from multiple industries that are strong buys of stocks trading under $20 per share and may be the perfect options for investors seeking fairly cheap stocks.</p>



<h2>Galiano Gold (GAU)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/gold1600-300x169.jpg" alt="An image of multiple gold bars. Gold prices"><div>Source: Shutterstock</div></div><p><strong>Galiano Gold&nbsp;</strong>(NYSE:<a href="https://investorplace.com/stock-quotes/gau-stock-quote/"><strong>GAU</strong></a>) is a gold property exploration company whose flagship mine is the Asako Gold Mine located in Ghana, West Africa. The mine typically produces between 120,000 and 130,000 ounces of gold annually.</p>



<p>On Feb. 16, Galiano Gold reported its earnings for the<a href="https://www.galianogold.com/news/news-details/2024/GALIANO-GOLD-REPORTS-Q4-AND-FULL-YEAR-2023-OPERATING-AND-FINANCIAL-RESULTS/default.aspx" target="_blank">&nbsp;</a><a href="https://www.galianogold.com/news/news-details/2024/GALIANO-GOLD-REPORTS-Q4-AND-FULL-YEAR-2023-OPERATING-AND-FINANCIAL-RESULTS/default.aspx">fourth quarter full year of 2023</a>, and it stated that total revenue increased by 3% year over year. And net income fell dramatically from $8 million in Q4 2022 to $366,000 in Q4 2023. cash generated from its operating activities more than doubled from the previously mentioned time period. GAU total gold production topped its expecations with 134,000 ounces of gold produced in 2023.</p>



<p>Gold prices are soaring to a new high, trading at over $1,300 per ounce. The rapid surge in gold prices, which have risen by over 13% in the last year, has helped propel GAU stock higher.</p>



<p>Over the past year, its share price has increased by over 140%, and the recent announcement that&nbsp;<a href="https://seekingalpha.com/news/4050081-galiano-gold-upgraded-to-outperform-at-bmo-capital-after-asanko-deal" target="_blank"><strong>BMO Capital</strong> upgraded GAU</a>&nbsp;from Market Perform to Outperform again which was a catalyst for a surge in share price.</p>



<p>Galiano Gold is a strong buy. It is a gold production company that is trading very inexpensively, making it a solid pick for investors seeking exposure to commodities, especially gold, which has seen tremendous growth.</p>



<h2>Viant Technology (DSP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/01/tech-stocks1600-300x169.png" alt="Business man using computer hand close up futuristic cyber space decentralized finance coding background, business data analytics programming online VPN network metaverse digital world technology. tech stocks"><div>Source: thinkhubstudio / Shutterstock.com</div></div><p><strong>Viant Technology</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dsp-stock-quote/"><strong>DSP</strong></a>) is an ad tech company that operates a data platform that typically uses generative AI technology to determine customer-based trends and solutions.</p>



<p>On Mar. 4, it released its earnings report for the&nbsp;<a target="_blank" href="https://investors.viantinc.com/news-releases/news-release-details/viant-technology-announces-fourth-quarter-and-full-year-2023">fourth quarter of the full year of 2023</a>, in which it stated that total revenue increased by 18% and gross profit rose by 41%.</p>



<p>Its share price has increased by over 150% just within this last year due to a number of factors, including the rise of investor interest in the company that specializes in utilizing generative AI technology and the fact that it has a history of profitability.</p>



<p>DSP should <a href="https://seekingalpha.com/article/4680354-viant-technology-stock-attractive-price-level-with-decent-upside-potential">continue to experience&nbsp;growth</a>, especially within the advertising space, which has been very profitable recently. It is a strong buy&nbsp;<a href="https://investorplace.com/industries/technology/" target="_blank">to invest in technology stocks</a>&nbsp;that offer great exposure to generative AI, which is a continually advancing field.</p>



<h2>Blue Owl Capital (OBDC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/06/best_stocks_to_buy_now_google-300x169.jpg" alt="best investments: a hand using the touchpad on a laptop. a concept image of figures and charts is emerging from the laptop screen."><div>Source: Shutterstock</div></div><p><strong>Blue Owl Capital</strong>&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/obdc-stock-quote/"><strong>OBDC</strong></a>) is a business investment company that provides various financing tools, including unsecured loans, direct lending, warrants, preferred stock, and mezzanine loans.</p>



<p>Blue Owl Capital&rsquo;s share price has increased by 24% within the last year, which is impressive compared to its peers. One of the biggest draw factors to Blue Owl Capital is its dividend yield, which is approximately 9.67% on an annual basis. Its dividend has increased over the last two years, and its latest dividend amount is thirty-seven cents per share.</p>



<p>On Feb. 21, OBDC reported earnings for the&nbsp;<a target="_blank" href="https://www.blueowlcapitalcorporation.com/investors/news-events/press-releases/detail/66/blue-owl-capital-corporation-reports-full-year-results-and">fourth quarter and full year of 2023</a>, stating that net income dropped slightly by 2% and investment income increased by 17%. In addition, it&nbsp;<a target="_blank" href="https://seekingalpha.com/news/4069997-blue-owl-capital-gaap-nii-of-051-beats-by-003-tii-of-41123m-beats-by-1348m">beat analyst expectations</a>&nbsp;regarding investment income and earnings per share.</p>



<p>Blue Owl Capital is a strong buy due to its outstanding dividend yield and impressive growth over the past year, which may offer investors continued upside as an investment opportunity.</p>



<p><em>As of this writing, Noah Bolton&nbsp;did not hold (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a></em></p>
<div><p>Noah has about a year of freelance writing experience. He&rsquo;s worked with Investopedia dealing with
topics such as the stock market and financial news.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/the-3-best-under-20-stocks-to-buy-in-april-2024/">The 3 Best Under $20 Stocks to Buy in April 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

The 3 Best Under $20 Stocks to Buy in April 2024

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Three underdog businesses have surfaced as strong rivals in the ever-changing stock market, with plans to take the lead in each by 2030. These have placed themselves in a smart position to profit from growing industries and new trends. </p>



<p>The first one&rsquo;s asset base and revenue streams have significantly expanded with the recent acquisition of a multifamily platform. This action demonstrates the company&rsquo;s dedication to diversifying its portfolio for long-term growth, further improving its position in the real estate market.</p>



<p>The second one can completely transform the advertising technology sector, as seen by the impressive expansion of its high-value clientele. As a result of the flood of important clients, Viant has seen significant revenue growth, indicating its ability to optimize profitability and market share in a highly competitive environment.</p>



<p>Last, the third one&rsquo;s strategic reorganization has made it a strong contender in the finance industry, especially for micro, small, and medium-sized businesses (MSMBs). The organization is broadening its market reach by concentrating on revenue diversification and matching its offerings with client segmentation. These prospects are based on fundamental strategic objectives and industry trends, not just conjecture.</p>



<h2>RMR (RMR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/realestate1600-300x169.jpg" alt="Hands holding a miniature house and keys"><div>Source: Shutterstock</div></div><p><strong>RMR&rsquo;s</strong> (NASDAQ: <span><a href="https://investorplace.com/stock-quotes/rmr-stock-quote/"><strong>RMR</strong></a></span>) purchase of the CARROLL Multifamily Platform results in a stronger asset base and more diverse income streams. The acquisition of over&nbsp;<a href="https://s21.q4cdn.com/317921054/files/doc_presentations/2024/03/25/RMR-Investor-Presentation_March-2024_FINAL.pdf" target="_blank">500 real estate experts</a>&nbsp;and 66 properties with over 21,000 units has driven the total assets under management (AUM) to rise by more than 15% sequentially to over $41 billion from $5.5 billion. Private capital AUM represents the company&rsquo;s successful entry into this market, with over $13 billion in AUM or around 32% of total AUM.</p>



<p>Additionally, the development trajectory of RMR&rsquo;s residential business indicates the company&rsquo;s focus on enhancing its expertise in home asset management. RMR Residential currently&nbsp;<a href="https://finance.yahoo.com/news/rmr-group-inc-nasdaq-rmr-135307434.html" target="_blank">oversees $5.5 billion</a>&nbsp;in assets and is well-positioned for future growth following the CARROLL purchase. The company&rsquo;s $200 million General Partner Fund (Fund VII) contributes substantial equity cash, allowing the gross acquisition of almost $3 billion of residential real estate. Thus, this calculated move demonstrates RMR&rsquo;s dedication to capitalizing on the residential real estate market&rsquo;s long-term growth potential.</p>



<p>Overall, with over&nbsp;<a href="https://finance.yahoo.com/news/rmr-group-inc-nasdaq-rmr-135307434.html" target="_blank">$200 million in cash reserves</a>&nbsp;and no corporate debt, RMR has a healthy liquidity position indicative of its smart financial management. Therefore, by distributing its income across many real estate sectors, such as multifamily, office and mortgage REITs, RMR&rsquo;s revenue diversification approach reduces market risk and improves growth opportunities.&nbsp;</p>



<h2>Viant Technology (DSP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/03/digital-advertising-1600-300x169.jpg" alt="Close up hand holding mobile with Digital Advertising and icons, Digital Marketing concept. digital ad stocks"><div>Source: weedezign via Shutterstock</div></div><p><strong>Viant</strong> <strong>Technology</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/dsp-stock-quote/"><strong>DSP</strong></a></span>) saw a notable increase in clients who made sizable revenue contributions. Over 2023, there was a&nbsp;<a href="https://investors.viantinc.com/news-releases/news-release-details/viant-technology-announces-fourth-quarter-and-full-year-2023" target="_blank">20% rise&nbsp;</a>in clients who generated over $1 million in contribution ex-traffic acquisition costs (<span>TAC</span>). This shows how well the programmatic advertising specialist has drawn in and kept hold of high-value clients, which is critical to increasing sales and profitability.</p>



<p>Even more rapidly, contribution ex-TAC &mdash; a crucial performance indicator in the advertising technology sector &mdash; grew to&nbsp;<a href="https://finance.yahoo.com/news/viant-technology-inc-nasdaq-dsp-151326884.html" target="_blank">$42.6 million&nbsp;</a>in the fourth quarter of 2023. By comparison, this is a significant 28% gain over the same period last year. The rise in contribution ex-TAC demonstrates Viant&rsquo;s ability to maximize revenue after deducting TAC and reflects the company&rsquo;s effectiveness in monetizing its advertising platform.</p>



<p>Lastly, customers have embraced Viant&rsquo;s AI product suite, which includes cutting-edge tools like the Viant Data platform and the AI Bid Optimizer. Through artificial intelligence (<span>AI</span>), the AI Bid Optimizer assisted clients in realizing substantial CPM savings, an&nbsp;<a href="https://finance.yahoo.com/news/viant-technology-inc-nasdaq-dsp-151326884.html" target="_blank">average of 35%</a>. Therefore, this demonstrates how well AI-driven solutions work to maximize advertising budgets and improve clients&rsquo; returns on investment.</p>



<h2>StoneCo (STNE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/stne-1600-300x169.jpg" alt="Cellphone with logo of Brazilian fintech business Stone Company (StoneCo) on screen in front of website"><div>Source: T. Schneider / Shutterstock.com</div></div><p><strong>StoneCo&rsquo;s</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/stne-stock-quote/"><strong>STNE</strong></a></span>) organizational reorganization aligns with customer segmentation, allowing customized solutions and improved client interaction. The organization emphasizes various customer categories, ranging from small- to medium-sized enterprises. This is bolstered by expanding the active client base for payments and banking (in 2023).&nbsp;<a href="https://investors.stone.co/static-files/36b7a563-9765-444d-a924-065914cf8594" target="_blank">Nearly 3.5 million</a>&nbsp;active clients were part of StoneCo&rsquo;s payment active client base, which grew by 37% annually.&nbsp;</p>



<p>Similarly, the number of active banking clients tripled annually to&nbsp;<a href="https://investors.stone.co/static-files/e5c4104f-71fd-43e1-86ab-97747cc0fbf2" target="_blank">reach 2.1 million</a>. This reflects StoneCo&rsquo;s capacity to successfully target and cater to various clientele groups, stimulating expansion and involvement. Moreover, the financial services platform&rsquo;s revenues increased by 24.4%, driving a 20.1% rise in StoneCo&rsquo;s total revenue and income over 2022. Hence, these patterns show how StoneCo has increased its market share.</p>



<p>Finally, StoneCo&rsquo;s MSMB total payment volume (TPV) climbed to&nbsp;<a href="https://investors.stone.co/static-files/e5c4104f-71fd-43e1-86ab-97747cc0fbf2" target="_blank">BRL350 billion</a>&nbsp;a year ($69 billion), a 20% annual growth. This noteworthy expansion results from StoneCo&rsquo;s growing market share and volume of transactions with micro to medium-sized enterprises. Thus, StoneCo has successfully gained market share and increased transaction activity among its clientele, as can be seen in the acceleration of MSMB TPV.</p>



<p><em>On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.</em><a href="https://investorplace.com/stock-quotes/-stock-quote/"></a></p>
<div><p>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/secret-stock-picks-3-stealth-companies-poised-to-rule-the-market-by-2030/">Secret Stock Picks: 3 Stealth Companies Poised to Rule the Market by 2030</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Secret Stock Picks: 3 Stealth Companies Poised to Rule the Market by 2030

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>The technology industry has performed well over the past year. The generative AI boom and other innovative tech products and services have triggered a monumental shift in the market.</p>



<p>A benchmark ETF, the <strong>Technology Select Sector SPDR Fund</strong> (NYSEARCA:<a href="https://investorplace.com/stock-quotes/xlk-stock-quote/"><strong>XLK</strong></a>), has increased by over 38% in the last year, while the <strong>S&amp;P 500</strong> has only returned 26%.</p>



<p>Despite experiencing a large rally, many of these may offer investors increased upside throughout 2024.</p>



<p>Below are three technology companies that have performed well. Especially this last year, partly due to the overall interest and excitement swirling around companies implementing AI technology and having a strong buy rating.</p>



<h2>Celestica (CLS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/cls1600-300x169.png" alt="Person holding cellphone with website of Canadian electronics company Celestica Inc. (CLS) on screen in front of logo. Focus on center of phone display. Unmodified photo."><div>Source: T. Schneider / Shutterstock.com</div></div><p><strong>Celestica</strong>&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/cls-stock-quote/"><strong>CLS</strong></a>) provides supply chain and cloud technology services and products for various industries, including industrials, aerospace and defense, and communications.</p>



<p>Over this past year, CLS&rsquo;s share price has more than tripled, partly due to its strong earnings growth and&nbsp;<a target="_blank" href="https://seekingalpha.com/article/4680319-celestica-is-still-an-attractive-ai-buy-despite-the-recent-run-up">growing list of generative AI products</a>.</p>



<p>On Jan. 29, Celestica reported earnings for the&nbsp;<a target="_blank" href="https://corporate.celestica.com/news-releases/news-release-details/celestica-announces-fourth-quarter-2023-financial-results">fourth quarter of the full year 2023</a>, in which it stated that total revenue increased by 5% and net income nearly doubled to $84 million compared to the previous year. It also provided guidance for the first quarter of 2024, which mentioned that anticipated revenue for the quarter is between $2.025 billion and $2.175 billion, which is in line with reported revenue for Q4 2023.</p>



<p>Celestica has been able to ride the overall technology boom in the stock market higher over primarily just this last year. With its&nbsp;<a target="_blank" href="https://seekingalpha.com/article/4680319-celestica-is-still-an-attractive-ai-buy-despite-the-recent-run-up">growing exposure to cloud technology and generative AI</a>&nbsp;products and services, Celestica is a solid, strong buy option. CLS is poised to continue its upward trajectory and still offer investors a fair valuation.</p>



<h2>Nvidia (NVDA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/05/nvda1600-4-300x169.png" alt="Nvidia corporation (NVDA) logo displayed on smartphone with stock market chart background. Nvidia is a global leader in artificial intelligence hardware and software"><div>Source: Poetra.RH / Shutterstock.com</div></div><p><strong>Nvidia</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/"><strong>NVDA</strong></a>) is primarily a semiconductor manufacturer that produces GPUs for gaming PCs, cloud-based software, and data center applications. It also provides hardware and software for a machine learning and generative AI platform.</p>



<p>On Feb. 21, Nvidia announced its earnings result for the&nbsp;<a target="_blank" href="https://investor.nvidia.com/news/press-release-details/2024/NVIDIA-Announces-Financial-Results-for-Fourth-Quarter-and-Fiscal-2024/">fourth quarter of fiscal year 2024</a>, stating that total revenue more than tripled to just over $22 billion year-over-year. Earnings per share for Q4 FY 2023 were fifty-seven cents, and for Q4 FY 2024, they increased to four dollars and ninety-three cents. Most notably, its data center revenue rose more than fivefold, and its professional visualization segment saw its total sales double year-over-year.</p>



<p>After this stellar earnings report that beat analysts&rsquo; expectations, its share price surged by over 16% and has continued to experience growth.</p>



<p>Nvidia is a very strong option for investors seeking exposure to the technology industry, which has been on a very impressive trajectory recently. Strong attention is being placed on the burgeoning generative AI industry and other related fields in which NVDA is a massive player. This has assisted in the large increase in Nvidia&rsquo;s share price, which has more than tripled since April 2023.</p>



<h2>Viant Technology (DSP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/tech-stocks-1600-300x169.png" alt="A hexagonal grid with different tech-related icons; Tech stocks illustration. Best Tech stocks. tech stocks trading at bargain prices"><div>Source: whiteMocca / Shutterstock</div></div><p><strong>Viant Technology</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dsp-stock-quote/"><strong>DSP</strong></a>) is an advertising tech company that offers a data platform that uses AI to determine cost-effective media solutions and omnichannel marketing services for marketing agencies.</p>



<p>Over this past year, its share price has more than doubled. It has seen a resurgence in investors&rsquo; interest following its dramatic decline in 2021, when it started trading publicly.</p>



<p>Investors are seeking greater exposure to the online advertising industry, which has been performing very well lately. Such is the case with Meta Platforms (NASDAQ:<a href="https://investorplace.com/stock-quotes/meta-stock-quote/"><strong>META</strong></a>),&nbsp;<a href="https://seekingalpha.com/news/4061745-meta-in-charts-ad-revenue-jumps-24-from-last-year" target="_blank">for example. Its advertising revenue</a>&nbsp;is its most profitable segment, which increased in revenue by over 24% from Q4 2022 to Q4 2023.</p>



<p>On Mar. 4, earnings for the&nbsp;<a target="_blank" href="https://investors.viantinc.com/news-releases/news-release-details/viant-technology-announces-fourth-quarter-and-full-year-2023">fourth quarter of the full year 2023 were released,</a>&nbsp;stating that total revenue increased by 18% year-over-year. It reported a net loss of 8 million for Q4 2022 and a net income of $3.3 million in Q4 2023. These earnings were mostly in line with what analysts expected. It announced first-quarter guidance in which expected revenue should land in the range of $49 million to $52 million.</p>



<p>Viant had a rough start in 2021 going public, but more recently, it has performed remarkably well through the last year. With the growing importance of online advertising, it is a great time for investors to look into investing in DSP, which is still trading at a great valuation and could offer significant upside with a strong buy rating.</p>



<p><em>As of this writing, Noah Bolton&nbsp;did not hold (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a></em></p>
<div><p>Noah has about a year of freelance writing experience. He&rsquo;s worked with Investopedia dealing with
topics such as the stock market and financial news.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/wall-street-favorites-3-tech-stocks-with-strong-buy-ratings-for-april-2024/">Wall Street Favorites: 3 Tech Stocks With Strong Buy Ratings for April 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Wall Street Favorites: 3 Tech Stocks With Strong Buy Ratings for April 2024

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Finding opportunities that have the potential to provide large profits is crucial. Three tech companies have emerged as strong competitors with promising futures in the tech sector. These businesses have drawn notice for their strategic initiatives that set them up for future growth, market dominance and strong financial results.</p>



<p>The first one stands out for its outstanding financial results, showcasing significant gross merchandise value (GMV) gains and a growing user base. This illustrates its ability to draw in and keep buyers and sellers, which results in increased transaction amounts and earnings.</p>



<p>Likewise, the latter is notable for its remarkable rise in Remaining Performance Obligation (RPO), which indicates robust revenue visibility and the capacity to win long-term customer commitments. Investors will feel more confident about the company&rsquo;s stability and potential revenue streams.</p>



<p>The third, meanwhile, has invested in state-of-the-art AI-driven product suites that improve campaign performance and customer experience, marking a major advancement in innovation. </p>



<p>These three businesses offer a combination of sound financial standing, promising markets and astute strategic planning.</p>



<h2>GigaCloud (GCT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/ecommerce1600d-min-300x169.jpg" alt="e-commerce stocks, Image of small shopping bags sitting in a shopping cart on a computer. Strong Buy E-Commerce Stocks"><div>Source: Shutterstock</div></div><p><strong>GigaCloud</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/gct-stock-quote/"><strong>GCT</strong></a></span>) has shown impressive financial results. For instance, over the 12 months (ended 2023), GigaCloud Marketplace GMV climbed by&nbsp;<a href="https://investors.gigacloudtech.com/news-releases/news-release-details/gigacloud-technology-inc-announces-fourth-quarter-2023-and-year" target="_blank">53.3% year-over-year</a>&nbsp;(YoY). Active 3P buyers jumped by 20.5% to 5,010, while active sellers expanded by 45.5% YoY to 815. At $158,569, the spend per active customer increased by 27.2% YoY. These operational KPIs show how well GigaCloud can draw in and keep buyers and sellers, which increases transaction volumes and earnings.</p>



<p>Comparably, net income increased for the entire year from $24.0 million in 2022 to&nbsp;<a href="https://investors.gigacloudtech.com/news-releases/news-release-details/gigacloud-technology-inc-announces-fourth-quarter-2023-and-year" target="_blank">$94.1 million in 2023</a>, and the net income margin increased from 4.9% to 13.4%. GigaCloud&rsquo;s capacity to effectively turn revenues into profits, as seen by the notable net income and margin growth, demonstrates solid operational performance and successful cost-control strategies.</p>



<p>Moreover, through the acquisitions of&nbsp;<a href="https://investors.gigacloudtech.com/static-files/c6140b97-a5b3-4545-a61a-c11a8a593faa" target="_blank">Noble House and Wondersign</a>, GigaCloud has proactively increased its product line scope, market penetration, and technological prowess. In short, incorporating Wondersign improves GigaCloud&rsquo;s digital signage and customer-facing solutions. Lastly, the acquisition of Noble House has expanded warehouse capacity, product SKUs and supplier networks.&nbsp;</p>



<h2>Palo Alto (PANW)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/panw-stock-1-300x169.jpg" alt="Palo Alto Networks (PANW) logo on corporate building"><div>Source: Sundry Photography / Shutterstock.com</div></div><p>The RPO of <strong>Palo Alto</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/panw-stock-quote/"><strong>PANW</strong></a></span>) increased to&nbsp;<a href="https://investors.paloaltonetworks.com/news-releases/news-release-details/palo-alto-networks-reports-fiscal-second-quarter-2024-financial" target="_blank">$10.8 billion in Q2 fiscal 2024</a>, representing 22% annual growth. The notable increase in RPO indicates a sizable backlog of contracted revenue, which leads to potential stable revenue streams. Palo Alto&rsquo;s ability to obtain long-term customer commitments and preserve solid customer relationships is reflected in its backlog. With a rising RPO, Palo Alto Networks has improved revenue visibility and predictability.&nbsp;</p>



<p>Thanks to this visibility, the company can more accurately project future financial performance, allocate resources and make well-informed strategic decisions. Additionally, Palo Alto&rsquo;s financial estimates for 2024 signify solid revenue, billings and EPS growth projections. Total billings of between $10.10 billion and $10.20 billion are projected, indicating an increase of&nbsp;<a href="https://investors.paloaltonetworks.com/news-releases/news-release-details/palo-alto-networks-reports-fiscal-second-quarter-2024-financial" target="_blank">10% to 11% YoY.</a></p>



<p>PANW&rsquo;s estimated top-line in 2024 stands between&nbsp;<a href="https://investors.paloaltonetworks.com/static-files/ba0097e4-ce00-484a-a2d5-94bfc5b24759" target="_blank">$7.95 billion to $8 billion</a>, growing between 15% and 16% annually. Similarly, the forecasted non-GAAP operating margin falls between 26.5% and 27.0%, and the projected diluted non-GAAP net income per share is between $5.45 and $5.55. To conclude, the outlook strongly emphasizes approaching growth and profitability in a balanced manner, with goals for increased revenue and improved margins.&nbsp;</p>



<h2>Viant (DSP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/advertising1600-300x169.jpg" alt="graphic of laptop screens displaying ad space"><div>Source: Shutterstock</div></div><p><strong>Viant</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/dsp-stock-quote/"><strong>DSP</strong></a></span>) has made considerable investments in creating cutting-edge product suites that use AI and machine learning to improve the customer experience and boost campaign performance. Examples of these suites are AI Bid Optimizer and the Viant Data platform. The AI Bid Optimizer has garnered significant traction among clients. This enables them to realize an average of&nbsp;<a href="https://investors.viantinc.com/news-releases/news-release-details/viant-technology-announces-fourth-quarter-and-full-year-2023" target="_blank">35% cost per mile&nbsp;</a>(CPM) savings.&nbsp;</p>



<p>Moreover, Viant intends to introduce a&nbsp;<a target="_blank" href="https://investors.viantinc.com/static-files/f8229159-9a45-44af-a22a-d0d7c81cf0e2">second-generation</a>&nbsp;optimizer, which should result in even greater cost savings. The Viant Data platform, which activates first-party data without depending on cookies, has observed good early adoption rates. This has led to higher spending on the platform and outsized campaign results, especially among top customers.</p>



<p>Furthermore, among the four enterprise-grade self-service demand-side platforms available in the market, Viant is&nbsp;<a href="https://finance.yahoo.com/news/viant-technology-inc-nasdaq-dsp-151326884.html" target="_blank">one of the only two</a>&nbsp;that is buy-side solely, indicating that it is not involved in representing any publisher inventory. In summary, advertisers have responded favorably to the company&rsquo;s focus on providing mid-market companies with a more data-driven platform. </p>



<p>Finally, the platform provides superior results and support compared to platforms tailored to substantial international brands&rsquo; needs.</p>



<p><em>On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.</em></p>
<div><p>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/next-big-thing-3-tech-stocks-to-outperform-the-market-by-2028/">Next Big Thing: 3 Tech Stocks to Outperform the Market by 2028</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Next Big Thing: 3 Tech Stocks to Outperform the Market by 2028

OBDC

PANW

STNE

Press Releases

Viant Wins 2024 BIG Innovation Award

Viant to Present at Upcoming Investor Conference

Viant Integrates with PurpleLab™

Viant Bolsters Data Platform with AI

Management

El Pollo Loco Holdings, Inc. Appoints Liz Williams as Chief Executive Officer and Director

Viant Announces Date of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Viant Achieved Carbon Neutrality for Calendar Year 2023

Viant Technology Announces Fourth Quarter and Full Year 2023 Financial Results

Viant Announces Date of First Quarter 2024 Financial Results and Conference Call

LOCO

SFIX

AudioEye

XIAO-I Corporation - American Depositary Shares

XIAO-I

Agora

Digital Turbine

Argo Blockchain plc - American Depositary Shares

Argo Blockchain

Bit Digital

CoreCard

Consensus Cloud Solutions, Inc. - Common Stock

Consensus Cloud Solns

Cheetah Mobile Inc. American Depositary Shares, each representing fifty (50) Class A Ordinary Shares